Viewing Study NCT06691360


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-01-18 @ 3:50 AM
Study NCT ID: NCT06691360
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-15
First Post: 2024-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
Sponsor: Akeso
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module